FindTrial
Sign In

Quality ofrecovery with pericapsular nerve block with use of dexamethasone as an adjuvant

Efficacy of ultrasound guided pericapsular nerve group block(PENG) with dexamethasone as an adjuvant on postoperative Quality of recovery (QoR) and Analgesia for pertrochanteric fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029303
Enrollment
80
Registered
2020-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Pericapsular nerve group block (PENG): Ultrasound guided pericapsular nerve group block using 30ml of 0.25% of levobupivacaine with dexamethasone as an adjuvant. Control Intervention1:

Sponsors

GGS MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I-III Scheduled for Hip surgeries

Exclusion criteria

Exclusion criteria: Patientâ??s refusal to give consent. Coagulopathy. Infection at the injection site. Allergy to local anaesthetics. Severe cardiopulmonary disease (>=ASA IV) diabetic or other neuropathies . Patients receiving opioids for chronic analgesic therapy. Inability to comprehend visual analogue scale (VAS)

Design outcomes

Primary

MeasureTime frame
To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +dexamethasone (Group D) To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +normal saline .(Group C) To Compare Quality of recovery (QoR) of both Group D and Group C. Timepoint: To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +dexamethasone (Group D) To assess the Quality of recovery (QoR) at 24 hrs postoperatively following Pericapsular nerve group block in Levobupivacaine +normal saline .(Group C) To Compare Quality of recovery (QoR) of both Group D and Group C.—

Secondary

MeasureTime frame
VAS will be measured at PACU , 2,4,8,12 and 24h. Cumulative opioid consumption at 24 hTimepoint: VAS at 2,4,8,12 and 24h Cumulative opioid at 24h—

Countries

India

Contacts

Public ContactGurkaran kaur sidhu

Baba Farid University of Health sciences Faridkot.

sugarsidhu2007@outlook.com09876766522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026